Drug Profile
Recombinant human growth hormone - Amoytop Biotech
Alternative Names: rhGH - Amoytop BiotechLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Amoytop Biotech
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for clinical-Phase-Unknown development in Unspecified in China
- 06 Jan 2016 Clinical trials in Undefined indication in China (unspecified route)